MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ebiom.2022.103894

Медицинская библиотека · EBioMedicine · 2022

Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications.

McElvaney Oisin F, Asakura Takanori, Meinig Suzanne L, Torres-Castillo Jose L, Hagan Robert S, Gabillard-Lefort Claudie, Murphy Mark P, Thorne Leigh B, Borczuk Alain, Reeves Emer P, Zumwalt Ross E, Mikami Yu, Carroll Tomas P, Okuda Kenichi, Hogan Grace, McElvaney Oliver J, Clarke Jennifer, McEvoy Natalie L, Mallon Patrick W, McCarthy Cormac, Curley Ger, Wolfgang Matthew C, Boucher Richard C, McElvaney Noel G

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Interleukin-6 (IL-6) is elevated in SARS-CoV-2 infection. IL-6 regulates acute-phase proteins, such as alpha-1 antitrypsin (AAT), a key lung anti-protease. We investigated the protease-anti-protease balance in the circulation and pulmonary compartments in SARS-CoV-2 acute respiratory distress syndrome (ARDS) compared to non-SARS-CoV-2 ARDS (nsARDS) and the effects of tocilizumab (IL-6 receptor antagonist) on anti-protease defence in SARS-CoV-2 infection.

METHODS

Levels and activity of AAT and neutrophil elastase (NE) were measured in plasma, airway tissue and tracheal secretions (TA) of people with SARS-CoV-2 ARDS or nsARDS. AAT and IL-6 levels were evaluated in people with moderate SARS-CoV-2 infection who received standard of care +/- tocilizumab.

FINDINGS: AAT plasma levels doubled in SARS-CoV-2 ARDS. In lung parenchyma AAT levels were increased, as was the percentage of neutrophils involved in NET formation. A protease-anti-protease imbalance was detected in TA with active NE and no active AAT. The airway anti-protease, secretory leukoprotease inhibitor was decreased in SARS-CoV-2-infected lungs and cleaved in TA. In nsARDS, plasma AAT levels were elevated but TA samples had less AAT cleavage, with no detectable active NE in most samples. Induction of AAT in ARDS occurred mainly through IL-6. Tocilizumab down-regulated AAT during SARS-CoV-2 infection.

INTERPRETATION: There is a protease-anti-protease imbalance in the airways of SARS-CoV-2-ARDS patients. This imbalance is a target for anti-protease therapy.

FUNDING: NIH Serological Sciences Network, National Heart, Lung, and Blood Institute and National Institute of Diabetes and Digestive and Kidney Diseases.

Для цитирования: McElvaney Oisin F, Asakura Takanori, Meinig Suzanne L, Torres-Castillo Jose L, Hagan Robert S, Gabillard-Lefort Claudie, Murphy Mark P, Thorne Leigh B, Borczuk Alain, Reeves Emer P, Zumwalt Ross E, Mikami Yu, Carroll Tomas P, Okuda Kenichi, Hogan Grace, McElvaney Oliver J, Clarke Jennifer, McEvoy Natalie L, Mallon Patrick W, McCarthy Cormac, Curley Ger, Wolfgang Matthew C, Boucher Richard C, McElvaney Noel G. Protease-anti-protease compartmentalization in SARS-CoV-2 ARDS: Therapeutic implications.. EBioMedicine. 2022. DOI: 10.1016/j.ebiom.2022.103894.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.